Anti-fungal Agents Market 2027 by Drug Type, Therapeutic Indication, Dosage form and Geography | The Insight Partners

Anti-fungal Agents Market to 2027 - Global Analysis and Forecasts by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines); Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others); Dosage form (Powder, Ointment, Drugs, Other) and Geography

Report Code: TIPRE00008775 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Anti-fungal agents are a drug which detects and eradicates fungal pathogens from body with minimal toxic side effects to a body. Antifungal agents are also known as antimycotic medication which is used to prevent fungal infection. Unclean and unhygienic are favorable environment for fungal growth. Fungal infection cause diseases such as candidiasis, mucormycosis, fungal pneumonia, and various other diseases

MARKET DYNAMICS

The Anti-fungal agents market is anticipated to grow in the forecast period owing to the rising progress of drug resistance, besides rising concern regarding health issue is also contributing positively. Moreover, increasing healthcare expenditure and increasing individual medical spending capacity in developed regions are anticipated to increase the demand for anti-fungal agents.

MARKET SCOPE

The "Global Anti-fungal agents Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti-fungal agents market with detailed market segmentation by drug type, therapeutic indication, dosage form and geography. The global Anti-fungal agents market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anti-fungal agents market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Anti-fungal agents market is segmented on the basis of drug type, therapeutic indication, dosage form. Based on drug type, the market is segmented into echinocandins, azoles, polyenes, and allylamines . Based on therapeutic indication, the market is segmented into Aspergillosis, Dermatophytosis , Candidiasis and others. On the basis of dosage form the market is segmented into powders, ointments, drugs and others.




Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Anti-fungal agents market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anti-fungal agents market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Anti-fungal agents market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti-fungal agents market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Anti-fungal agents market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Anti-fungal agents market are anticipated to lucrative growth opportunities in the future with the rising demand for Anti-fungal agents market in the global market. Below mentioned is the list of few companies engaged in the Anti-fungal agents market.

The report also includes the profiles of key Anti-fungal agents market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott Laboratories, Inc.
- Zydus Cadila Healthcare Ltd.
- Astellas Pharma, Inc.
- Basilea Pharmaceutica AG
- Bayer Healthcare LLC
- Bristol-Myers Squibb Pharmaceuticals, Ltd.
- Teva Pharmaceutical Industries, Ltd.
- Sun Pharmaceutical Industries, Ltd.
- Pfizer, Inc.
- Mylan Pharmaceuticals, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-fungal Agents Market - By Drug Type
1.3.2 Anti-fungal Agents Market - By Therapeutic Indication
1.3.3 Anti-fungal Agents Market - By Dosage form
1.3.4 Anti-fungal Agents Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTI-FUNGAL AGENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTI-FUNGAL AGENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTI-FUNGAL AGENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-FUNGAL AGENTS - GLOBAL MARKET OVERVIEW
6.2. ANTI-FUNGAL AGENTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTI-FUNGAL AGENTS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ECHINOCANDINS
7.3.1. Overview
7.3.2. Echinocandins Market Forecast and Analysis
7.4. AZOLES
7.4.1. Overview
7.4.2. Azoles Market Forecast and Analysis
7.5. POLYENES
7.5.1. Overview
7.5.2. Polyenes Market Forecast and Analysis
7.6. ALLYLAMINES
7.6.1. Overview
7.6.2. Allylamines Market Forecast and Analysis
8. ANTI-FUNGAL AGENTS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC INDICATION
8.1. OVERVIEW
8.2. THERAPEUTIC INDICATION MARKET FORECASTS AND ANALYSIS
8.3. ASPERGILLOSIS
8.3.1. Overview
8.3.2. Aspergillosis Market Forecast and Analysis
8.4. DERMATOPHYTOSIS
8.4.1. Overview
8.4.2. Dermatophytosis Market Forecast and Analysis
8.5. CANDIDIASIS
8.5.1. Overview
8.5.2. Candidiasis Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. others Market Forecast and Analysis
9. ANTI-FUNGAL AGENTS MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
9.1. OVERVIEW
9.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
9.3. POWDER
9.3.1. Overview
9.3.2. Powder Market Forecast and Analysis
9.4. OINTMENT
9.4.1. Overview
9.4.2. Ointment Market Forecast and Analysis
9.5. DRUGS
9.5.1. Overview
9.5.2. Drugs Market Forecast and Analysis
9.6. OTHER
9.6.1. Overview
9.6.2. Other Market Forecast and Analysis

10. ANTI-FUNGAL AGENTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anti-fungal Agents Market Overview
10.1.2 North America Anti-fungal Agents Market Forecasts and Analysis
10.1.3 North America Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.1.4 North America Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.1.5 North America Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.1.6 North America Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-fungal Agents Market
10.1.6.1.1 United States Anti-fungal Agents Market by Drug Type
10.1.6.1.2 United States Anti-fungal Agents Market by Therapeutic Indication
10.1.6.1.3 United States Anti-fungal Agents Market by Dosage form
10.1.6.2 Canada Anti-fungal Agents Market
10.1.6.2.1 Canada Anti-fungal Agents Market by Drug Type
10.1.6.2.2 Canada Anti-fungal Agents Market by Therapeutic Indication
10.1.6.2.3 Canada Anti-fungal Agents Market by Dosage form
10.1.6.3 Mexico Anti-fungal Agents Market
10.1.6.3.1 Mexico Anti-fungal Agents Market by Drug Type
10.1.6.3.2 Mexico Anti-fungal Agents Market by Therapeutic Indication
10.1.6.3.3 Mexico Anti-fungal Agents Market by Dosage form
10.2. EUROPE
10.2.1 Europe Anti-fungal Agents Market Overview
10.2.2 Europe Anti-fungal Agents Market Forecasts and Analysis
10.2.3 Europe Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.2.5 Europe Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.2.6 Europe Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-fungal Agents Market
10.2.6.1.1 Germany Anti-fungal Agents Market by Drug Type
10.2.6.1.2 Germany Anti-fungal Agents Market by Therapeutic Indication
10.2.6.1.3 Germany Anti-fungal Agents Market by Dosage form
10.2.6.2 France Anti-fungal Agents Market
10.2.6.2.1 France Anti-fungal Agents Market by Drug Type
10.2.6.2.2 France Anti-fungal Agents Market by Therapeutic Indication
10.2.6.2.3 France Anti-fungal Agents Market by Dosage form
10.2.6.3 Italy Anti-fungal Agents Market
10.2.6.3.1 Italy Anti-fungal Agents Market by Drug Type
10.2.6.3.2 Italy Anti-fungal Agents Market by Therapeutic Indication
10.2.6.3.3 Italy Anti-fungal Agents Market by Dosage form
10.2.6.4 Spain Anti-fungal Agents Market
10.2.6.4.1 Spain Anti-fungal Agents Market by Drug Type
10.2.6.4.2 Spain Anti-fungal Agents Market by Therapeutic Indication
10.2.6.4.3 Spain Anti-fungal Agents Market by Dosage form
10.2.6.5 United Kingdom Anti-fungal Agents Market
10.2.6.5.1 United Kingdom Anti-fungal Agents Market by Drug Type
10.2.6.5.2 United Kingdom Anti-fungal Agents Market by Therapeutic Indication
10.2.6.5.3 United Kingdom Anti-fungal Agents Market by Dosage form
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-fungal Agents Market Overview
10.3.2 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.3.5 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.3.6 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-fungal Agents Market
10.3.6.1.1 Australia Anti-fungal Agents Market by Drug Type
10.3.6.1.2 Australia Anti-fungal Agents Market by Therapeutic Indication
10.3.6.1.3 Australia Anti-fungal Agents Market by Dosage form
10.3.6.2 China Anti-fungal Agents Market
10.3.6.2.1 China Anti-fungal Agents Market by Drug Type
10.3.6.2.2 China Anti-fungal Agents Market by Therapeutic Indication
10.3.6.2.3 China Anti-fungal Agents Market by Dosage form
10.3.6.3 India Anti-fungal Agents Market
10.3.6.3.1 India Anti-fungal Agents Market by Drug Type
10.3.6.3.2 India Anti-fungal Agents Market by Therapeutic Indication
10.3.6.3.3 India Anti-fungal Agents Market by Dosage form
10.3.6.4 Japan Anti-fungal Agents Market
10.3.6.4.1 Japan Anti-fungal Agents Market by Drug Type
10.3.6.4.2 Japan Anti-fungal Agents Market by Therapeutic Indication
10.3.6.4.3 Japan Anti-fungal Agents Market by Dosage form
10.3.6.5 South Korea Anti-fungal Agents Market
10.3.6.5.1 South Korea Anti-fungal Agents Market by Drug Type
10.3.6.5.2 South Korea Anti-fungal Agents Market by Therapeutic Indication
10.3.6.5.3 South Korea Anti-fungal Agents Market by Dosage form
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-fungal Agents Market Overview
10.4.2 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.4.5 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.4.6 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-fungal Agents Market
10.4.6.1.1 South Africa Anti-fungal Agents Market by Drug Type
10.4.6.1.2 South Africa Anti-fungal Agents Market by Therapeutic Indication
10.4.6.1.3 South Africa Anti-fungal Agents Market by Dosage form
10.4.6.2 Saudi Arabia Anti-fungal Agents Market
10.4.6.2.1 Saudi Arabia Anti-fungal Agents Market by Drug Type
10.4.6.2.2 Saudi Arabia Anti-fungal Agents Market by Therapeutic Indication
10.4.6.2.3 Saudi Arabia Anti-fungal Agents Market by Dosage form
10.4.6.3 U.A.E Anti-fungal Agents Market
10.4.6.3.1 U.A.E Anti-fungal Agents Market by Drug Type
10.4.6.3.2 U.A.E Anti-fungal Agents Market by Therapeutic Indication
10.4.6.3.3 U.A.E Anti-fungal Agents Market by Dosage form
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-fungal Agents Market Overview
10.5.2 South and Central America Anti-fungal Agents Market Forecasts and Analysis
10.5.3 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.5.5 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.5.6 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-fungal Agents Market
10.5.6.1.1 Brazil Anti-fungal Agents Market by Drug Type
10.5.6.1.2 Brazil Anti-fungal Agents Market by Therapeutic Indication
10.5.6.1.3 Brazil Anti-fungal Agents Market by Dosage form
10.5.6.2 Argentina Anti-fungal Agents Market
10.5.6.2.1 Argentina Anti-fungal Agents Market by Drug Type
10.5.6.2.2 Argentina Anti-fungal Agents Market by Therapeutic Indication
10.5.6.2.3 Argentina Anti-fungal Agents Market by Dosage form

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ANTI-FUNGAL AGENTS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ZYDUS CADILA HEALTHCARE LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTELLAS PHARMA, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BASILEA PHARMACEUTICA AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER HEALTHCARE LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRISTOL-MYERS SQUIBB PHARMACEUTICALS, LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TEVA PHARMACEUTICAL INDUSTRIES, LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SUN PHARMACEUTICAL INDUSTRIES, LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MYLAN PHARMACEUTICALS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1.Abbott Laboratories, Inc.
2.Zydus Cadila Healthcare Ltd.
3.Astellas Pharma, Inc.
4.Basilea Pharmaceutica AG
5.Bayer Healthcare LLC
6.Bristol-Myers Squibb Pharmaceuticals, Ltd.
7.Teva Pharmaceutical Industries, Ltd.
8.Sun Pharmaceutical Industries, Ltd.
9.Pfizer, Inc.
10.Mylan Pharmaceuticals, Inc.
TIPRE00008775
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Tags Anti-fungal Agents Market Anti-fungal Agents Market Research Anti-fungal Agents Market Insight Anti-fungal Agents Market Trends Anti-fungal Agents Market Forecast Anti-fungal Agents Market Share Anti-fungal Agents Market 2027 Anti-fungal Agents Market Growth Anti-fungal Agents Industry Sector Anti-fungal Agents PDF Report Anti-fungal Agents Analysis Anti-fungal Agents Market 2027 Anti-fungal Agents Research Competitive Analysis The Insight Partners
Pricing

Free

20%

customization on Pre-Booking